Response by Wiberg et al to Letter Regarding Article, “Neuroprotective Effects of the Glucagon-Like Peptide-1 Analog Exenatide After Out-of-Hospital Cardiac Arrest: A Randomized Controlled Trial”
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
We appreciate the interest of Ma and colleagues in our article reporting the neuroprotective effects of the glucagon-like peptide-1 analog exenatide after out-of-hospital cardiac arrest.1
Ma et al suggest that the neutral findings of our trial could be caused by propofol, which was used to sedate the patients during the period of targeted temperature management. To the best of our …